Xenetic Biosciences, Inc. Skyrocketed
Tue, Jul 13, 2021 at 05:30 PM
Xenetic Biosciences, Inc. (XBIO:NASDAQ) soared at $2.46, a gain of 21.2%. On Mon, Jul 12, 2021, XBIO:NASDAQ hit a New 2-Week Intraday High of $2.05. From Mon, Jun 28, 2021, the stock recorded 44.44% Up Days and 60.00% Green Days
The stock spiked on Mon, Jun 14, 2021 at $2.74 with a volume of 2M+, and its share price has been moving sideways in recent weeks.
About Xenetic Biosciences, Inc. (XBIO:NASDAQ)
Xenetic Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics.
Top 10 Gainers:
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 128.79%
- Sohu.com Limited (SOHU:NASDAQ), 27.58%
- PLx Pharma Inc. (PLXP:NASDAQ), 27.19%
- Howard Bancorp, Inc. (HBMD:NASDAQ), 26.7%
- VRPX (VRPX:NASDAQ), 25.56%
- Exela Technologies, Inc. (XELA:NASDAQ), 25.07%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 24.34%
- KOR (KOR:NASDAQ), 22.48%
- Xenetic Biosciences, Inc. (XBIO:NASDAQ), 21.18%
- Bridgeline Digital, Inc. (BLIN:NASDAQ), 20.8%